0
61
Psychiatric News   |   January 05, 2001 
Volume 36 Number 1 page 9-9
Association News
  • Print
  • E-mail
    Recipient(s) will receive an email with a link (good for 72 hours) to 'Guidelines to Define APA’s Relationship With Industry' and do not need to have Psychiatric News account to access the content.
    Example: John Doe
    CC Me:
    Enter your valid email address. Example: jdoe@example.com
    Separate multiple email address with semi-colons (up to 5).
    's Psychiatric News: 'Guidelines to Define APA’s Relationship With Industry'
    Subject for your email.
    (Optional, message will truncate at 1000 characters)
    Copyright © in the material you requested is held by The American Psychiatric Association (unless otherwise noted). This email ability is provided as a courtesy, and by using it you agree that you are requesting the material solely for personal, non-commercial use, and that it is subject to The American Psychiatric Association's Terms of Use. The information provided in order to email this topic will not be used to send unsolicited email, nor will it be furnished to third parties. Please refer to The American Psychiatric Association's Privacy Policy for further information.
    Copyright © American Psychiatric Association. All rights reserved.
  • Share
  • Reprints
Guidelines to Define APA’s Relationship With Industry
text A A A
View Disclosures and Other Information
The development of guidelines governing the interaction of APA and the pharmaceutical industry is expected to benefit both.
The Board of Trustees has approved the formation of an ad hoc committee charged with developing guidelines for APA’s interactions with the pharmaceutical industry.
The Board made that decision at last month’s meeting in Washington, D.C. The committee will be made up of APA members and staff from APA and the American Psychiatric Foundation (APF) and will report back to the Board in March.
Pharmaceutical companies provide funding for several APA activities ranging from the annual meeting to fellowships, and they pay for advertising in its publications.
Although APA receives most of its revenue from other sources, including dues, investments, and publication sales, some members have perceived pharmaceutical funding as influencing APA activities and believe that APA relies too heavily on pharmaceutical funding. In addition, some members believe that the pharmaceutical companies should cut funding for social events while increasing funding for APA’s advocacy, education, and research activities.
"Our goal is to ensure a positive and appropriate relationship between APA and the pharmaceutical industry," said Steven Rubloff, executive director of the American Psychiatric Foundation, which serves as APA’s primary interface with industry. "Establishing the ad hoc committee to develop governing principles is an important step for both APA and industry."
Rubloff pointed out that APA is not the only party that wants the guidelines: the pharmaceutical industry welcomes them as well. "Industry is concerned about how they are perceived by APA members. They share the belief that the development of these guidelines is a timely idea," he said.
The creation of the ad hoc committee represents a continuation of APA’s efforts to refocus its relationship with the pharmaceutical industry to encourage more funding of advocacy, education, and research, particularly fellowships. For example, while advertising and annual meeting support has remained constant since 1998, industry support for APA fellowships and education/research has nearly doubled since 1997, according to Rubloff.
APA Medical Director Steven Mirin, M.D., pointed out at the Board meeting that 129 APA fellowships were funded externally, including a number supported by the pharmaceutical industry in 2000. Of these, 43 are research related, 31 focus on minority issues or went to minority psychiatrists, and 55 focus on public policy and psychiatry.
In addition to the guidelines project, Mirin, along with APA President Daniel Borenstein, M.D., noted that APA will continue to hold meetings with the pharmaceutical industry with the goal of fostering a better understanding of the needs and goals of each. The Board endorsed that idea. ▪

Interactive Graphics

Video

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Copyright ©
American
Psychiatric
Association